Pectus ExcavatumPENCT07312448
Comparative Analysis Of Modified Vs. Classical Nuss Technique In The Surgical Correction Of Pectus Excavatum "
An observational study of Pectus Excavatum, run by University Hospital, Strasbourg, France at 1 site in France.
Trial summary
Although the NUSS technique has become the standard minimally invasive procedure for correcting this deformity, there is a lack of comparative data between the classic and modified NUSS techniques. Read more about this study
- Who is it for?
- Ages 11 to 18 years
- Conditions the study is for
- Pectus Excavatum
- How many people
- 80 participants
- Where
- 1 siteFrance
- Study dates
- 2 Dec 2024to Feb 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 11 to 18 years
- All sexes
- Child, Adult
Study population: Patients aged 11 to 18 years underwent surgery between 2010 and 2024 using either the classic or modified Nuss technique. - Patient with a Haller index of 2.25 or higher.
Who may be able to join
- Patients aged 11 to 18 years.
- Patients who underwent surgery between 2010 and 2024 using either the classic or modified Nuss technique. - Patient with a Haller index of 2.25 or higher.
Who cannot join
- Patients with a Haller score below 2.25.
- Patients who have undergone surgery using alternative techniques such as Ravitch or modified Ravitch.
- Patients under 11 years of age or over 19 years of age.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
France1 site, 1 recruiting
- Recruiting
Service de Chirurgie Pédiatrique - Réanimation - CHU de Strasbourg - France
Strasbourg, 67091
Isabelle TALON, MD, PhD, 33 3 88 12 72 96, Isabelle.TALON@chru-strasbourg.fr
Isabelle TALON, MD, PhD
About this study
Official title: Single-Center Retrospective Comparative Analysis Of Modified Vs. Classical Nuss Technique In The Surgical Correction Of Pectus Excavatum "
Although the NUSS technique has become the standard minimally invasive procedure for correcting this deformity, there is a lack of comparative data between the classic and modified NUSS techniques. This research aims to fill this gap by comparing these two methods in terms of various outcomes, such as operative time, postoperative pain control, length of stay in the intensive care unit, and overall cosmetic results.
This study addresses the need to optimize surgical techniques to improve patient outcomes. By evaluating these two approaches, the research seeks to provide insights that could lead to better management strategies for patients with pectus excavatum, potentially influencing future clinical practices.
- Conditions
- Pectus Excavatum
- Keywords
- Pectus Excavatum, Nuss techniques, Modified Nuss Technique
- Medical subject headings
- Funnel Chest
What is being measured
The primary outcome is the main question the study is designed to answer.
Operating time (in minutes)
Comparaison Of Modified Vs. Classical Nuss Technique In The Surgical Correction Of Pectus Excavatum in terms of operating time criterion (in minutes)
Measured: Operating time (in minutes)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted31 Dec 2025
- Study start2 Dec 2024
- Primary completionFeb 2026 (estimated)
- Study completionFeb 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Pectus ExcavatumStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Retrospective
- Enrolment
- 80 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Hospital, Strasbourg, France
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07312448
- Sponsor's protocol ID
- 9450
- Acronym
- PE
- Status last verified
- Dec 2025
- First submitted
- 9 Dec 2025
- Last updated
- 31 Dec 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 31 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Single-Center Retrospective Comparative Analysis Of Modified Vs. Classical Nuss Technique In The Surgical Correction Of Pectus Excavatum "
- ClinicalTrials.gov ID
- NCT07312448
- Acronym / sponsor ID
- PE / 9450
- Conditions
- Pectus Excavatum
- Keywords
- Pectus Excavatum, Nuss techniques, Modified Nuss Technique
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 80 participants (estimated)
- Lead sponsor
- University Hospital, Strasbourg, FranceUniversity, hospital or other
- Study start
- 2 Dec 2024 (actual)
- Primary completion
- Feb 2026 (estimated)
- Study completion
- Feb 2026 (estimated)
- First posted
- 31 Dec 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Although the NUSS technique has become the standard minimally invasive procedure for correcting this deformity, there is a lack of comparative data between the classic and modified NUSS techniques. This research aims to fill this gap by comparing these two methods in terms of various outcomes, such as operative time, postoperative pain control, length of stay in the intensive care unit, and overall cosmetic results.
This study addresses the need to optimize surgical techniques to improve patient outcomes. By evaluating these two approaches, the research seeks to provide insights that could lead to better management strategies for patients with pectus excavatum, potentially influencing future clinical practices.
Study design
- Observational model
- Case only
- Time perspective
- Retrospective
Who may qualify
- Ages
- 11 to 18 years
- Sex
- All
- Age groups
- Child, Adult
- Study population
- Patients aged 11 to 18 years underwent surgery between 2010 and 2024 using either the classic or modified Nuss technique. - Patient with a Haller index of 2.25 or higher.
Key inclusion criteria (2 listed)
- Patients aged 11 to 18 years.
- Patients who underwent surgery between 2010 and 2024 using either the classic or modified Nuss technique. - Patient with a Haller index of 2.25 or higher.
Key exclusion criteria (3 listed)
- Patients with a Haller score below 2.25.
- Patients who have undergone surgery using alternative techniques such as Ravitch or modified Ravitch.
- Patients under 11 years of age or over 19 years of age.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Operating time (in minutes)
Time frame: Operating time (in minutes)
Comparaison Of Modified Vs. Classical Nuss Technique In The Surgical Correction Of Pectus Excavatum in terms of operating time criterion (in minutes)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 Dec 2025.
Related trials for Pectus Excavatum
RecruitingObservational study
Biopsychosocial Risk Influences on the Development and Generation of Early-Onset Chronic Pain
Juvenile Idiopathic Arthritis (JIA), Fibromyalgia
Active, not recruiting
Comprehensive Study of Post-surgical Pain After Pectus or Spine Surgery
Pain, Postoperative, Excavatum, Pectus
Recruiting
ES Catheter vs Cryoablation After Pectus Surgery
Pectus Excavatum
Active, not recruitingObservational study
Postoperative and Chronic Pain Genetic Spine and Pectus Surgery Study
Scoliosis, Kyphosis
Active, not recruiting
Pectus Excavatum Camouflage (IT)
Pectus Excavatum
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Pectus Excavatum, run by University Hospital, Strasbourg, France at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 31 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Isabelle TALON, MD, PhD (33 3 88 12 72 96, Isabelle.TALON@chru-strasbourg.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Operating time (in minutes) (time frame: Operating time (in minutes)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Dec 2025.